Company Profile

Virogenomics Inc (AKA: Activated Cell Systems~Virogenomics BioDevelopment)
Profile last edited on: 7/3/19      CAGE: 3EMR4      UEI:

Business Identifier: Diagnostic devices for autoimmune disease, stroke, and infectious disease and other R&D
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12909 SW 68th Parkway Suite 430
Portland, OR 97223
   (503) 626-1144
Location: Single
Congr. District: 01
County: Washington

Public Profile

Virogenomics Inc, spun off from research done at Oregon Health & Science University, is using gene-based automation in the discovery and validation of novel drug targets and the development of new drugs for the treatment of human disease. Also dba Virogenomic Biodevelopment, the firm is working to develop technologies from OHSU in the areas of cancer, stroke, cardiovascular disease and antiviral diseases. The firm is privately held and uses a business strategy of identifying and obtaining rights to early-stage technologies, then managing and developing these technologies to a critical phase before spinning off the developed technologies into new start-up companies. Virogenomics has obtained rights to technologies in three general disease areas including autoimmune diseases, stroke, and infectious diseases. The autoimmune technology was spun-off in 2004 into a subsidiary named Artielle ImmunoTherapeutics; The stroke technology was spun off into its own entity, NeuroProtect Inc; the firm also created I D Biopharma via a consolidation of infectious disease technologies from Virogenomics and OHSU.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Adolph J Ferro -- Chairman

  Jeff King -- Chief Executive Officer.

  Renee Lynn Shirley -- COO

  Grazyna Adamus

  Richard B Alexander

  Eric W Barklis

  Gregory G Burrows

  Brian Clare

  Fred L Heffron

  James B Hicks

  Jianya Huan

  Marilyn Huckans

  Jeffrey S King -- Chief Operating Officer

  Jennifer M Loftis

  Gilbert N Miller -- Executive Vice President; Chief Financial Officer

  Ashlee V Moses

  Halina Offner

  Halina Offner -- Principal

  Roger P Simon

  Arthur A Vandenbark